PARTNER NEWS:Mon, Mar 4, 11:00 AM, Zacks
Aclaris (ACRS) Upgraded to Buy: Here's Why Aclaris (ACRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Tue, Feb 27, 6:20 AM, Zacks
Esperion Therapeutics (ESPR) Reports Q4 Loss, Tops Revenue Estimates Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 5.66% and 20.16%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Featured MNV Articles: Exxon Mobil Reports Before the Open on 4/26 -- Options Contracts Expire the Same Day
Friday, April 19, 12:19 PM ET, by Market News Video Staff
According to NextEarningsDate.com, the Exxon Mobil (NYSE: XOM) XOM next earnings date is projected to ...
MNDY Makes Notable Cross Below Critical Moving Average
Friday, April 19, 11:56 AM ET, by Market News Video Staff
In trading on Friday, shares of monday.com Ltd (MNDY) crossed below their 200 day moving ...
Tile Shop Holdings Becomes Oversold (TTSH)
Friday, April 19, 11:56 AM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Relative Strength Alert For Hims & Hers Health
Friday, April 19, 11:55 AM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Oversold Conditions For Denali Therapeutics (DNLI)
Friday, April 19, 11:55 AM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|